116 related articles for article (PubMed ID: 1376847)
1. Effects of long-term administration of isradipine on renal hemodynamics and sodium metabolism.
Francischetti EA; Barroso I; da Silva A; Fagundes VG
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S90-2. PubMed ID: 1376847
[TBL] [Abstract][Full Text] [Related]
2. Effects of isradipine on hypertension and renal hemodynamics.
Siamopoulos KC; Elisaf M; Dardamanis M; Sferopoulos G; Pappas M
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S87-9. PubMed ID: 1376846
[TBL] [Abstract][Full Text] [Related]
3. Long-term antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.
Wittenberg C; Rosenfeld JB
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S93-5. PubMed ID: 1376848
[TBL] [Abstract][Full Text] [Related]
4. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
5. Metabolic, hematological, and cardiac effects of long-term isradipine treatment in mild-to-moderate essential hypertension.
Meriç M; Gören T; Atilgan D; Eren N; Cubukçu A; Koylan N
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S58-60. PubMed ID: 1376837
[TBL] [Abstract][Full Text] [Related]
6. Effect of isradipine on renal haemodynamics and systemic blood pressure changes induced by intravenous infusion of endothelin in healthy humans.
Sørensen SS; Jensen JD; Madsen JK; Pedersen EB
Nephrol Dial Transplant; 1995; 10(8):1324-31. PubMed ID: 8538922
[TBL] [Abstract][Full Text] [Related]
7. Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: a randomized, double-blind, controlled trial.
Ottesen LH; Aagaard NK; Kiszka-Kanowitz M; Rehling M; Henriksen JH; Pedersen EB; Flyvbjerg A; Bendtsen F
Hepatology; 2001 Sep; 34(3):471-7. PubMed ID: 11526531
[TBL] [Abstract][Full Text] [Related]
8. Long-term (2-year) isradipine data in the treatment of mild-to-moderate hypertension.
D'Hont G; Meurant JP; Clement DL; Rorive G; Hermans L; De Keyser P; Westelinck KJ
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S46-8. PubMed ID: 1376834
[TBL] [Abstract][Full Text] [Related]
9. Clinical equivalence of once-daily administration of a modified-release formulation of isradipine and twice-daily administration of the standard formulation. Multicentre Study Group.
Holmes D; Moullet C
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S61-5. PubMed ID: 1376839
[TBL] [Abstract][Full Text] [Related]
10. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
[TBL] [Abstract][Full Text] [Related]
11. Effects of isradipine on renal hemodynamics in renal transplant patients treated with cyclosporine.
Ahmed K; Michael B; Burke JF
Clin Nephrol; 1997 Nov; 48(5):307-10. PubMed ID: 9403215
[TBL] [Abstract][Full Text] [Related]
12. Effect of manidipine, a new calcium antagonist, on intrarenal hemodynamics in essential hypertension.
Murakami K; Kimura G; Imanishi M; Sanai T; Kawano Y; Kojima S; Yoshida K; Abe H; Ashida T; Yoshimi H
Blood Press Suppl; 1992; 3():114-8. PubMed ID: 1343278
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
Fitscha P; Meisner W; Hitzenberger G
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S12-4. PubMed ID: 1720478
[TBL] [Abstract][Full Text] [Related]
14. Tolerability of isradipine in the treatment of mild-to-moderate hypertension in general practice: a large-scale surveillance study.
Hermans L; Bogaert M; Degaute JP; Rorive G; Six R; Bara L; Lanssiers P; De Keyser P; Westelinck KJ
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S38-45. PubMed ID: 1376833
[TBL] [Abstract][Full Text] [Related]
15. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
Olsen NV
Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
[TBL] [Abstract][Full Text] [Related]
16. Effects of the calcium antagonist manidipine on renal hemodynamics and function in dogs: comparison with nifedipine.
He H; Tamaki T; Aki Y; Kiyomoto H; Iwao H; Miyatake A; Abe Y
Blood Press Suppl; 1992; 3():68-74. PubMed ID: 1343294
[TBL] [Abstract][Full Text] [Related]
17. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
[TBL] [Abstract][Full Text] [Related]
18. Repetitive natriuresis and blood pressure. Long-term calcium entry blockade with isradipine.
Krusell LR; Jespersen LT; Schmitz A; Thomsen K; Pedersen OL
Hypertension; 1987 Dec; 10(6):577-81. PubMed ID: 2447016
[TBL] [Abstract][Full Text] [Related]
19. Regression of cardiac hypertrophy in hypertensive patients by long-term treatment with isradipine.
Török E; Borbás S; Lengyel M; Zorándi A
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S79-83. PubMed ID: 1376844
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive therapy with ketanserin: effects on central and renal hemodynamics, and microalbuminuria.
Casagrande P; Valvo E; Bedogna V; Loschiavo C; Giorgetti P; Graziani MS; Maschio G
Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):79-83. PubMed ID: 2307549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]